Workshop report: Malaria vaccine development in Europe–preparing for the future

Nicola K. Viebig; Flavia D'Alessio; Simon J. Draper; B. Kim Lee Sim; Benjamin Mordmüller; Paul W. Bowyer; Adrian J.F. Luty; Stefan Jungbluth; Chetan E. Chitnis; Adrian V.S. Hill; Peter Kremsner; Alister Craig; Clemens H.M. Kocken; Odile Leroy

doi:10.1016/j.vaccine.2015.09.074

Workshop report: Malaria vaccine development in Europe–preparing for the future

Nicola K. Viebig, Flavia D'Alessio, Simon J. Draper, B. Kim Lee Sim, Benjamin Mordmüller, Paul W. Bowyer, Adrian J.F. Luty, Stefan Jungbluth, Chetan E. Chitnis, Adrian V.S. Hill, Peter Kremsner, Alister Craig, Clemens H.M. Kocken, Odile Leroy

Research output: Chapter in Book/Report/Conference proceeding › Conference contribution › peer-review

5 Citations (Scopus)

Abstract

The deployment of a safe and effective malaria vaccine will be an important tool for the control of malaria and the reduction in malaria deaths. With the launch of the 2030 Malaria Vaccine Technology Roadmap, the malaria community has updated the goals and priorities for the development of such a vaccine and is now paving the way for a second phase of malaria vaccine development. During a workshop in Brussels in November 2014, hosted by the European Vaccine Initiative, key players from the European, North American and African malaria vaccine community discussed European strategies for future malaria vaccine development in the global context. The recommendations of the European malaria community should guide researchers, policy makers and funders of global health research and development in fulfilling the ambitious goals set in the updated Malaria Vaccine Technology Roadmap.

Original language	English
Title of host publication	Vaccine
Publisher	Elsevier
Pages	6137-6144
Number of pages	8
Volume	33
Edition	46
DOIs	https://doi.org/10.1016/j.vaccine.2015.09.074
Publication status	Published - 1 Oct 2015

Keywords

Antigen discovery
Capacity building
Controlled human malaria infection
Correlates of protection
Malaria
Vaccine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.vaccine.2015.09.074

Cite this

Viebig, N. K., D'Alessio, F., Draper, S. J., Sim, B. K. L., Mordmüller, B., Bowyer, P. W., Luty, A. J. F., Jungbluth, S., Chitnis, C. E., Hill, A. V. S., Kremsner, P., Craig, A., Kocken, C. H. M., & Leroy, O. (2015). Workshop report: Malaria vaccine development in Europe–preparing for the future. In Vaccine (46 ed., Vol. 33, pp. 6137-6144). Elsevier. https://doi.org/10.1016/j.vaccine.2015.09.074

@inproceedings{6633543367a94921bce89ee991f4c8d5,

title = "Workshop report: Malaria vaccine development in Europe–preparing for the future",

abstract = "The deployment of a safe and effective malaria vaccine will be an important tool for the control of malaria and the reduction in malaria deaths. With the launch of the 2030 Malaria Vaccine Technology Roadmap, the malaria community has updated the goals and priorities for the development of such a vaccine and is now paving the way for a second phase of malaria vaccine development. During a workshop in Brussels in November 2014, hosted by the European Vaccine Initiative, key players from the European, North American and African malaria vaccine community discussed European strategies for future malaria vaccine development in the global context. The recommendations of the European malaria community should guide researchers, policy makers and funders of global health research and development in fulfilling the ambitious goals set in the updated Malaria Vaccine Technology Roadmap.",

keywords = "Antigen discovery, Capacity building, Controlled human malaria infection, Correlates of protection, Malaria, Vaccine",

author = "Viebig, \{Nicola K.\} and Flavia D'Alessio and Draper, \{Simon J.\} and Sim, \{B. Kim Lee\} and Benjamin Mordm{\"u}ller and Bowyer, \{Paul W.\} and Luty, \{Adrian J.F.\} and Stefan Jungbluth and Chitnis, \{Chetan E.\} and Hill, \{Adrian V.S.\} and Peter Kremsner and Alister Craig and Kocken, \{Clemens H.M.\} and Odile Leroy",

year = "2015",

month = oct,

day = "1",

doi = "10.1016/j.vaccine.2015.09.074",

language = "English",

volume = "33",

pages = "6137--6144",

booktitle = "Vaccine",

publisher = "Elsevier",

address = "Netherlands",

edition = "46",

}

TY - GEN

T1 - Workshop report: Malaria vaccine development in Europe–preparing for the future

AU - Viebig, Nicola K.

AU - D'Alessio, Flavia

AU - Draper, Simon J.

AU - Sim, B. Kim Lee

AU - Mordmüller, Benjamin

AU - Bowyer, Paul W.

AU - Luty, Adrian J.F.

AU - Jungbluth, Stefan

AU - Chitnis, Chetan E.

AU - Hill, Adrian V.S.

AU - Kremsner, Peter

AU - Craig, Alister

AU - Kocken, Clemens H.M.

AU - Leroy, Odile

PY - 2015/10/1

Y1 - 2015/10/1

N2 - The deployment of a safe and effective malaria vaccine will be an important tool for the control of malaria and the reduction in malaria deaths. With the launch of the 2030 Malaria Vaccine Technology Roadmap, the malaria community has updated the goals and priorities for the development of such a vaccine and is now paving the way for a second phase of malaria vaccine development. During a workshop in Brussels in November 2014, hosted by the European Vaccine Initiative, key players from the European, North American and African malaria vaccine community discussed European strategies for future malaria vaccine development in the global context. The recommendations of the European malaria community should guide researchers, policy makers and funders of global health research and development in fulfilling the ambitious goals set in the updated Malaria Vaccine Technology Roadmap.

AB - The deployment of a safe and effective malaria vaccine will be an important tool for the control of malaria and the reduction in malaria deaths. With the launch of the 2030 Malaria Vaccine Technology Roadmap, the malaria community has updated the goals and priorities for the development of such a vaccine and is now paving the way for a second phase of malaria vaccine development. During a workshop in Brussels in November 2014, hosted by the European Vaccine Initiative, key players from the European, North American and African malaria vaccine community discussed European strategies for future malaria vaccine development in the global context. The recommendations of the European malaria community should guide researchers, policy makers and funders of global health research and development in fulfilling the ambitious goals set in the updated Malaria Vaccine Technology Roadmap.

KW - Antigen discovery

KW - Capacity building

KW - Controlled human malaria infection

KW - Correlates of protection

KW - Malaria

KW - Vaccine

U2 - 10.1016/j.vaccine.2015.09.074

DO - 10.1016/j.vaccine.2015.09.074

M3 - Conference contribution

VL - 33

SP - 6137

EP - 6144

BT - Vaccine

PB - Elsevier

ER -

Workshop report: Malaria vaccine development in Europe–preparing for the future

Abstract

Keywords

UN SDGs

Access to Document

Fingerprint

Cite this